Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Multiple Investigational New Drugs with high potential for better treatment outcomes progressing through critical stages of clinical development
save 25 %
* Required Fields
Pay by invoice
Non-Alcoholic Steatohepatitis or NASH is a liver disorder that is characterized by the build-up of fat in liver in addition to inflammation and liver cell damage eventually progressing to cirrhosis. Currently lifestyle interventions are suggested for the treatment of NASH with no drugs having been approved for the condition.Multiple drugs are at the last stages of clinical trials with promising interim results while many more drugs are in early and mid-phase of clinical studies. Until now with no drugs approved for the condition of non-alcoholic steatohepatitis, there existed a huge unmet medical need. Poor performance of INDs tested for the condition of non-alcoholic steatohepatitis over the years has been attributed to poor preclinical models which has led to poor human translation of drug safety and efficacy in addition to use of conservative biomarkers during clinical trials. If companies can truly overcome the challenge of human translation of drug potential in terms of efficacy and safety, then non-alcoholic steatohepatitis as a manageable condition would be conquered within the next decade.The United States leads the way in the number of NASH-related patents published. The major challenge to demonstrate translation of clinical endpoint data in NASH trials has been to stop the disease progression to cirrhosis.
Global Drug Discovery and Early Development Outsourcing Growth Opportunities
Global RNA Therapeutics:Technology Growth Opportunities
Strategic Commercial Partnerships Transforming the Global Biobanking Market, 2020–2026
Novel Enzyme Technologies for Pharmaceutical Applications
Precision Immunotherapy Innovations Transforming Human Health and Wellness
Global Single Cell Genomics and Proteomics Market, Forecast to 2023
Chinese Clinical Laboratories Market, Forecast to 2025
Vietnamese Clinical Laboratories Market, Forecast to 2025
Thailand Clinical Laboratories Market, Forecast to 2025
Malaysian Clinical Laboratories Market, Forecast to 2025
video analytics market
heavy truck market
natural gas market
plastic recycling market
food waste market
nanophotonic equipment market
augmented reality market
diet food market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.